OFFER DEADLINE07/02/2019 00:00 - Europe/Brussels
EU RESEARCH FRAMEWORK PROGRAMMENot funded by an EU programme
ORGANISATION/COMPANYFundación para la Investigación Biomédica de Córdoba (FIBICO)
DEPARTMENTIMIBIC (Maimonides Biomedical Research Institute)
Aim of the call:
We are looking for excellent candidates to apply for:
Contract type: Sara Borrell
Position details: 3 years of postdoctoral contract, 26.866 € gross salary per year.
Funding Agency: National Institute of Health Carlos III (ISCIII)
Call: Strategic Action in Health 2019 (Acción Estratégica en Salud).
Eligibility criteria - Sara Borrell:
Candidates must have obtained their PhD after 1st of January 2015.*
*Candidates that have obtained their PhD before 1st of january 2015 may be eligible under certain circumstances.
Applicants should carefully check their CV against the specific eligibility conditions of call:
Selection Process: The process will consist of eligibility check an evaluation of merits of all CVs received (number and quality of publications, participation in research projects, mobility, and other merits). The best positioned candidates may be called for a personal interview in order to evaluate more precisely their skills.
How to Apply: Applicants should send their CV to: email@example.com stating clearly in the subject field of the email: a) the reference “AES-SB-2019” and b) the name of the research group or name of the PI of her/his interest.
The IMIBIC Research Groups are listed here
Deadline for expressions of interest: 7th of February of 2019.
Description of IMIBIC
The Maimonides Biomedical Research Institute of Cordoba, IMIBIC, located in Cordoba, southern Spain, is a partnership between the University of Cordoba and the Reina Sofia University Hospital. IMIBIC offers a multidisciplinary environment focused on results-oriented research and based on precision medicine and excellence in science. IMIBIC is accredited with the Excellence distinction from the Spanish National Institute of Health Carlos III and has the HR Excellence in Research Award of the European Commission.
The Institute is structured in research groups that cooperate in the implementation of 5 core scientific programmes: Active aging and Frailty; Nutrition and endocrine and metabolic diseases; Infectious and immunological diseases and organ transplantation; Cancer; and Chronic and Inflammatory Diseases. Our major goal is to promote biomedical innovation as a powerful engine for economic and social development. To this end, the Institute offers an active environment in which to conduct high-level scientific research. Regular seminars and research events offer the opportunity to meet with national and international speakers covering a diverse range of topics in biomedicine.
IMIBIC is a young and fast growing research institution; since 2015 it operates in the brand new IMIBIC building for basic and translational research which is strategically located within the University Health Sciences Campus, next to the Reina Sofia University Hospital. It hosts a wide variety of core facilities for researchers, including the Biomedical Research Support Units with brand new equipment and laboratories to support the technical needs of the IMIBIC community, as well as a Clinical Research Unit to support clinical trial studies. IMIBIC currently hosts over 600 researchers, of which nearly 400 combine their research activities with patient care.